Missing/wrong data?
Log in to edit
Sunitinib added to FOLFIRI versus FOLFIRI in patients with chemorefractory advanced adenocarcinoma of the stomach or lower esophagus: a randomized, placebo-controlled phase II AIO trial with serum biomarker program
scientific article
Author/s
author: Ludwig Fischer von Weikersthal, Susanna Hegewisch-Becker, Hansjochen Wilke, Hans-Joachim Schmoll
Work details
Publication date
August 31, 2016
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.